Profile Image
Robert C. Flanigan Photo
Name
Robert C. Flanigan
Degree
M.D.
Rank
Professor
Primary Department
Urology
Education
Medical School
Case Western Reserve University School of Medicine
Residencies
University Hospitals of Cleveland/Case Western Reserve University Urology
Publications
Koehne, EL; Flanigan, RC Re: Active Surveillance for Men with Intermediate Risk Prostate Cancer. European urology ;
Patel, HD; Clark, JI; Flanigan, RC Cytoreductive Nephrectomy for Synchronous Metastatic Renal Cell Carcinoma: Are There Any Favorable Risk Patients? The Journal of urology ;
Harris, AA; Korpics, M; Sherwani, Z; Farooq, A; Baldea, KG; Flanigan, R; Harkenrider, MM; Solanki, AA Patient and physician reported toxicity with two-fraction definitive high-dose-rate prostate brachytherapy: the impact of implant interval. Journal of contemporary brachytherapy ; 12 3
Kirshenbaum, EJ; Doshi, C; Dornbier, R; Blackwell, RH; Bajic, P; Gupta, GN; Gorbonos, A; Turk, TMT; Flanigan, RC; Baldea, KG Socioeconomic Disparities in the Acute Management of Stone Disease in the United States. Journal of Endourology ; 33 2
Kim, K; Kong, A; Flanigan, RC; Quek, ML; Hollowell, CMP; Vidal, PP; Branch, J; Dean, LA; Macias, V; Kajadacsy-Balla, AA; Fitzgibbon, ML; Cintron, D; Liu, L; Freeman, VL Pre-diagnostic carbohydrate intake and treatment failure after radical prostatectomy for early-stage prostate cancer. Cancer causes & control : CCC ; 30 3
Flanigan, RC Re: Sunitinib Alone or After Nephrectomy in Metastatic Renal-cell Carcinoma. European urology ; 75 5
Atieh, M; McIntire, PJ; Kilic, I; Picken, MM; Flanigan, RC; Barkan, GA; Pambuccian, SE Lipofuscin pigmentation (so called "melanosis") of the bladder. Diagnostic cytopathology ; 47 9
Solanki, AA; Mysz, ML; Patel, R; Surucu, M; Kang, H; Plypoo, A; Bajaj, A; Korpics, M; Martin, B; Hentz, C; Gupta, G; Farooq, A; Baldea, KG; Pawlowski, J; Roeske, J; Flanigan, R; Small, W; Harkenrider, MM Transitioning From a Low-Dose-Rate to a High-Dose-Rate Prostate Brachytherapy Program: Comparing Initial Dosimetry and Improving Workflow Efficiency Through Targeted Interventions. Advances in radiation oncology ; 4 1
Li, B; Kirshenbaum, EJ; Blackwell, RH; Gange, WS; Saluk, J; Zapf, MAC; Kothari, AN; Flanigan, RC; Gupta, GN Thirty-day hospital revisits after prostate brachytherapy: who is at risk? Prostate international ; 7 2
Saluk, JL; Blackwell, RH; Gange, WS; Zapf, MAC; Kothari, AN; Kuo, PC; Quek, ML; Flanigan, RC; Gupta, GN The LACE Score as a Tool to Identify Radical Cystectomy Patients at Increased Risk of 90-Day Readmission and Mortality. Current urology ; 12 1
Bajic, P; Joyce, CJ; Flanigan, RC Sunitinib and Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma. The Journal of urology ;
Kramer, H; Kuffel, G; Thomas-White, K; Wolfe, AJ; Vellanki, K; Leehey, DJ; Bansal, VK; Brubaker, L; Flanigan, R; Koval, J; Wadhwa, A; Zilliox, MJ Diversity of the midstream urine microbiome in adults with chronic kidney disease. International Urology and Nephrology ; 50 6
Blackwell, RH; Kothari, AN; Shah, A; Gang, W; Quek, ML; Luchette, FA; Flanigan, RC; Kuo, PC; Gupta, GN Adhesive Bowel Obstruction Following Urologic Surgery: Improved Outcomes with Early Intervention. Current urology ; 11 4